Clinical Trial Update: A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of 5-fluorouracil and ADH300004 in subjects with incurable solid tumors; the study is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• ADH300004 (ADH300004)

Snippet

Sponsor: Adherex Technologies, Inc. | Conditions: Neoplasms | Phase 1 | Status: SUSPENDED